New York University Perlmutter Cancer Center ( Site 0001)

New York, New York 10016

0 studies enrolling now · 1 studies all time

What they study most

Urinary Bladder Neoplasms

Studies at this site

• Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) — Running, not enrolling